ArticleParasitology research2025
Development of an immunochromatographic test for serodiagnosis of human sparganosis.
Article in Parasitology research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sparganosis is a parasitic zoonosis caused by the larval plerocercoid (sparganum) of tapeworms in the genus Spirometra. Humans become infected by ingesting raw or undercooked meat from second intermediate or paratenic hosts such as frogs, snakes, and wild boars by drinking water contaminated with cyclopoid copepods carrying the larval procercoid, or by applying frog meat poultices. The gold standard for diagnosis remains the molecular confirmation of plerocercoids in surgically removed specimens. However, because these larvae migrate in subcutaneous tissues and the central nervous system elicit a strong IgG antibody response, serological tests can provide valuable diagnostic support. Although several IgG antibody detection assays have been developed, they are often time consuming and require sophisticated equipment. To overcome these limitations, we developed an immunochromatography based diagnostic kit termed the "sparganosis whole-blood test kit" that employs a gold labeled secondary antibody and can be used directly on either whole blood or serum samples. When tested on simulated whole blood specimens, the kit achieved 100% sensitivity and 91.6% specificity; in paired serum samples, sensitivity and specificity were 100.0% and 84.1%, respectively. This rapid, user-friendly test can facilitate bedside diagnosis in high-risk populations (e.g., hospitalized patients), serve as a point-of-care tool in remote areas with limited medical infrastructure, and offer a noninvasive alternative when biopsy or excision is impractical.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.